Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 19(5): e0301786, 2024.
Article in English | MEDLINE | ID: mdl-38696537

ABSTRACT

OBJECTIVE: To systematically evaluate the evidence for the reliability, sensitivity and specificity of existing measures of vowel-initial voice onset. METHODS: A literature search was conducted across electronic databases for published studies (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PubMed Central, IEEE Xplore) and grey literature (ProQuest for unpublished dissertations) measuring vowel onset. Eligibility criteria included research of any study design type or context focused on measuring human voice onset on an initial vowel. Two independent reviewers were involved at each stage of title and abstract screening, data extraction and analysis. Data extracted included measures used, their reliability, sensitivity and specificity. Risk of bias and certainty of evidence was assessed using GRADE as the data of interest was extracted. RESULTS: The search retrieved 6,983 records. Titles and abstracts were screened against the inclusion criteria by two independent reviewers, with a third reviewer responsible for conflict resolution. Thirty-five papers were included in the review, which identified five categories of voice onset measurement: auditory perceptual, acoustic, aerodynamic, physiological and visual imaging. Reliability was explored in 14 papers with varied reliability ratings, while sensitivity was rarely assessed, and no assessment of specificity was conducted across any of the included records. Certainty of evidence ranged from very low to moderate with high variability in methodology and voice onset measures used. CONCLUSIONS: A range of vowel-initial voice onset measurements have been applied throughout the literature, however, there is a lack of evidence regarding their sensitivity, specificity and reliability in the detection and discrimination of voice onset types. Heterogeneity in study populations and methods used preclude conclusions on the most valid measures. There is a clear need for standardisation of research methodology, and for future studies to examine the practicality of these measures in research and clinical settings.


Subject(s)
Sensitivity and Specificity , Humans , Reproducibility of Results , Voice
2.
Mol Cell ; 44(3): 397-409, 2011 Nov 04.
Article in English | MEDLINE | ID: mdl-22055186

ABSTRACT

Single-stranded DNA-binding proteins play many roles in nucleic acid metabolism, but their importance during transcription remains unclear. Quantitative proteomic analysis of RNA polymerase II (RNApII) preinitiation complexes (PICs) identified Sub1 and the replication protein A complex (RPA), both of which bind single-stranded DNA (ssDNA). Sub1, homolog of mammalian coactivator PC4, exhibits strong genetic interactions with factors necessary for promoter melting. Sub1 localizes near the transcription bubble in vitro and binds to promoters in vivo dependent upon PIC assembly. In contrast, RPA localizes to transcribed regions of active genes, strongly correlated with transcribing RNApII but independently of replication. RFA1 interacts genetically with transcription elongation factor genes. Interestingly, RPA levels increase at active promoters in cells carrying a Sub1 deletion or ssDNA-binding mutant, suggesting competition for a common binding site. We propose that Sub1 and RPA interact with the nontemplate strand of RNApII complexes during initiation and elongation, respectively.


Subject(s)
DNA, Single-Stranded/metabolism , DNA-Binding Proteins/metabolism , Gene Expression Regulation, Fungal , RNA Polymerase II/metabolism , Replication Protein A/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Transcription Factors/metabolism , Transcription, Genetic , Base Sequence , Binding Sites , DNA-Binding Proteins/genetics , Molecular Sequence Data , Peptide Chain Elongation, Translational , Peptide Chain Initiation, Translational , Promoter Regions, Genetic , Proteomics/methods , RNA Polymerase II/genetics , Replication Protein A/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics , Transcription Factors/genetics , Transcription Initiation Site
3.
Genetics ; 187(1): 9-19, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20944015

ABSTRACT

Accurate chromosome segregation is dependent on the centromere-specific histone H3 isoform known generally as CenH3, or as Cse4 in budding yeast. Cytological experiments have shown that Cse4 appears at extracentromeric loci in yeast cells deficient for both the CAF-1 and HIR histone H3/H4 deposition complexes, consistent with increased nondisjunction in these double mutant cells. Here, we examined molecular aspects of this Cse4 mislocalization. Genome-scale chromatin immunoprecipitation analyses demonstrated broader distribution of Cse4 outside of centromeres in cac1Δ hir1Δ double mutant cells that lack both CAF-1 and HIR complexes than in either single mutant. However, cytological localization showed that the essential inner kinetochore component Mif2 (CENP-C) was not recruited to extracentromeric Cse4 in cac1Δ hir1Δ double mutant cells. We also observed that rpb1-1 mutants displayed a modestly increased Cse4 half-life at nonpermissive temperatures, suggesting that turnover of Cse4 is partially dependent on Pol II transcription. We used genome-scale assays to demonstrate that the CAF-1 and HIR complexes independently stimulate replication-independent histone H3 turnover rates. We discuss ways in which altered histone exchange kinetics may affect eviction of Cse4 from noncentromeric loci.


Subject(s)
Centromere/metabolism , Histones/metabolism , Nuclear Proteins/metabolism , Repressor Proteins/metabolism , Ribonucleases/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Animals , Cell Survival , Centromere/genetics , Chromatin Assembly and Disassembly , Chromosomal Proteins, Non-Histone/chemistry , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/metabolism , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Enzyme Activation , Genomics , Half-Life , Humans , Kinetochores/metabolism , Mutation , Protein Stability , Protein Transport , RNA Polymerase II/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/genetics , Temperature , Transcription, Genetic
4.
Genome Biol ; 11(7): R75, 2010.
Article in English | MEDLINE | ID: mdl-20637075

ABSTRACT

BACKGROUND: The use of genome-wide RNA abundance profiling by microarrays and deep sequencing has spurred a revolution in our understanding of transcriptional control. However, changes in mRNA abundance reflect the combined effect of changes in RNA production, processing, and degradation, and thus, mRNA levels provide an occluded view of transcriptional regulation. RESULTS: To partially disentangle these issues, we carry out genome-wide RNA polymerase II (PolII) localization profiling in budding yeast in two different stress response time courses. While mRNA changes largely reflect changes in transcription, there remains a great deal of variation in mRNA levels that is not accounted for by changes in PolII abundance. We find that genes exhibiting 'excess' mRNA produced per PolII are enriched for those with overlapping cryptic transcripts, indicating a pervasive role for nonproductive or regulatory transcription in control of gene expression. Finally, we characterize changes in PolII localization when PolII is genetically inactivated using the rpb1-1 temperature-sensitive mutation. We find that PolII is lost from chromatin after roughly an hour at the restrictive temperature, and that there is a great deal of variability in the rate of PolII loss at different loci. CONCLUSIONS: Together, these results provide a global perspective on the relationship between PolII and mRNA production in budding yeast.


Subject(s)
RNA Polymerase II/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics , Stress, Physiological/genetics , Transcription, Genetic , Alleles , Carbohydrate Metabolism/genetics , Databases, Genetic , Diamide/toxicity , Enzyme Activation/drug effects , Gene Expression Regulation, Fungal/drug effects , Genes, Fungal/genetics , Models, Genetic , Mutation/genetics , Open Reading Frames/genetics , Protein Binding/drug effects , RNA Polymerase II/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Temperature , Transcription, Genetic/drug effects
5.
J Biol Chem ; 285(36): 27581-9, 2010 Sep 03.
Article in English | MEDLINE | ID: mdl-20587420

ABSTRACT

Protein kinase B/Akt protein kinases control an array of diverse functions, including cell growth, survival, proliferation, and metabolism. We report here the identification of pleckstrin homology-like domain family B member 1 (PHLDB1) as an insulin-responsive protein that enhances Akt activation. PHLDB1 contains a pleckstrin homology domain, which we show binds phosphatidylinositol PI(3,4)P(2), PI(3,5)P(2), and PI(3,4,5)P(3), as well as a Forkhead-associated domain and coiled coil regions. PHLDB1 expression is increased during adipocyte differentiation, and it is abundant in many mouse tissues. Both endogenous and HA- or GFP-tagged PHLDB1 displayed a cytoplasmic disposition in unstimulated cultured adipocytes but translocated to the plasma membrane in response to insulin. Depletion of PHLDB1 by siRNA inhibited insulin stimulation of Akt phosphorylation but not tyrosine phosphorylation of IRS-1. RNAi-based silencing of PHLDB1 in cultured adipocytes also attenuated insulin-stimulated deoxyglucose transport and Myc-GLUT4-EGFP translocation to the plasma membrane, whereas knockdown of the PHLDB1 isoform PHLDB2 failed to attenuate insulin-stimulated deoxyglucose transport. Furthermore, adenovirus-mediated expression of PHLDB1 in adipocytes enhanced insulin-stimulated Akt and p70 S6 kinase phosphorylation, as well as GLUT4 translocation. These results indicate that PHLDB1 is a novel modulator of Akt protein kinase activation by insulin.


Subject(s)
Adipocytes/drug effects , Adipocytes/metabolism , Glucose Transporter Type 4/metabolism , Insulin/pharmacology , Intracellular Signaling Peptides and Proteins/metabolism , Proto-Oncogene Proteins c-akt/metabolism , 3T3-L1 Cells , Animals , Blood Proteins/chemistry , Enzyme Activation/drug effects , Gene Expression Regulation/drug effects , Gene Silencing , Glucose/metabolism , Humans , Intracellular Signaling Peptides and Proteins/chemistry , Intracellular Signaling Peptides and Proteins/deficiency , Intracellular Signaling Peptides and Proteins/genetics , Mice , Phosphatidylinositol Phosphates/metabolism , Phosphoproteins/chemistry , Phosphorylation/drug effects , Protein Structure, Tertiary , Protein Transport/drug effects , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Sequence Homology, Amino Acid
6.
PLoS Genet ; 4(11): e1000270, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19023413

ABSTRACT

Acetylation of histone H3 lysine 56 is a covalent modification best known as a mark of newly replicated chromatin, but it has also been linked to replication-independent histone replacement. Here, we measured H3K56ac levels at single-nucleosome resolution in asynchronously growing yeast cultures, as well as in yeast proceeding synchronously through the cell cycle. We developed a quantitative model of H3K56ac kinetics, which shows that H3K56ac is largely explained by the genomic replication timing and the turnover rate of each nucleosome, suggesting that cell cycle profiles of H3K56ac should reveal most first-time nucleosome incorporation events. However, since the deacetylases Hst3/4 prevent use of H3K56ac as a marker for histone deposition during M phase, we also directly measured M phase histone replacement rates. We report a global decrease in turnover rates during M phase and a further specific decrease in turnover at several early origins of replication, which switch from rapidly replaced in G1 phase to stably bound during M phase. Finally, by measuring H3 replacement in yeast deleted for the H3K56 acetyltransferase Rtt109 and its two co-chaperones Asf1 and Vps75, we find evidence that Rtt109 and Asf1 preferentially enhance histone replacement at rapidly replaced nucleosomes, whereas Vps75 appears to inhibit histone turnover at those loci. These results provide a broad perspective on histone replacement/incorporation throughout the cell cycle and suggest that H3K56 acetylation provides a positive-feedback loop by which replacement of a nucleosome enhances subsequent replacement at the same location.


Subject(s)
Cell Cycle , Histones/metabolism , Lysine/metabolism , Molecular Chaperones/metabolism , Saccharomyces cerevisiae/metabolism , Acetylation , DNA Replication , DNA, Fungal/metabolism , Histone Acetyltransferases/genetics , Histone Acetyltransferases/metabolism , Histones/genetics , Lysine/genetics , Molecular Chaperones/genetics , Saccharomyces cerevisiae/genetics
7.
Biochem J ; 411(3): 647-55, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18215134

ABSTRACT

Multiple studies have suggested that the protein kinase Akt/PKB (protein kinase B) is required for insulin-stimulated glucose transport in skeletal muscle and adipose cells. In an attempt to understand links between Akt activation and glucose transport regulation, we applied mass spectrometry-based proteomics and bioinformatics approaches to identify potential Akt substrates containing the phospho-Akt substrate motif RXRXXpS/T. The present study describes the identification of the Rab GAP (GTPase-activating protein)-domain containing protein TBC1D1 [TBC (Tre-2/Bub2/Cdc16) domain family, member 1], which is closely related to TBC1D4 [TBC domain family, member 4, also denoted AS160 (Akt substrate of 160 kDa)], as an Akt substrate that is phosphorylated at Thr(590). RNAi (RNA interference)-mediated silencing of TBC1D1 elevated basal deoxyglucose uptake by approx. 61% in 3T3-L1 mouse embryo adipocytes, while the suppression of TBC1D4 and RapGAP220 under the same conditions had little effect on basal and insulin-stimulated deoxyglucose uptake. Silencing of TBC1D1 strongly increased expression of the GLUT1 glucose transporter but not GLUT4 in cultured adipocytes, whereas the decrease in TBC1D4 had no effect. Remarkably, loss of TBC1D1 in 3T3-L1 adipocytes activated the mTOR (mammalian target of rapamycin)-p70 S6 protein kinase pathway, and the increase in GLUT1 expression in the cells treated with TBC1D1 siRNA (small interfering RNA) was blocked by the mTOR inhibitor rapamycin. Furthermore, overexpression of the mutant TBC1D1-T590A, lacking the putative Akt/PKB phosphorylation site, inhibited insulin stimulation of p70 S6 kinase phosphorylation at Thr(389), a phosphorylation induced by mTOR. Taken together, our data suggest that TBC1D1 may be involved in controlling GLUT1 glucose transporter expression through the mTOR-p70 S6 kinase pathway.


Subject(s)
Gene Expression Regulation , Glucose Transporter Type 1/metabolism , Nuclear Proteins/metabolism , Protein Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction , 3T3-L1 Cells , Adipocytes , Animals , Antibodies/immunology , Cricetinae , GTPase-Activating Proteins/metabolism , Glucose Transporter Type 1/genetics , Insulin/pharmacology , Mice , Mutation/genetics , Nuclear Proteins/genetics , Nuclear Proteins/immunology , Phosphorylation/drug effects , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Signal Transduction/drug effects , Substrate Specificity , TOR Serine-Threonine Kinases
8.
J Biol Chem ; 280(22): 21622-8, 2005 Jun 03.
Article in English | MEDLINE | ID: mdl-15799971

ABSTRACT

Insulin signaling through protein kinase Akt/protein kinase B (PKB), a downstream element of the phosphatidylinositol 3-kinase (PI3K) pathway, regulates diverse cellular functions including metabolic pathways, apoptosis, mitogenesis, and membrane trafficking. To identify Akt/PKB substrates that mediate these effects, we used antibodies that recognize phosphopeptide sites containing the Akt/PKB substrate motif (RXRXX(p)S/T) to immunoprecipitate proteins from insulin-stimulated adipocytes. Tryptic peptides from a 250-kDa immunoprecipitated protein were identified as the protein kinase WNK1 (with no lysine) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, consistent with a recent report that WNK1 is phosphorylated on Thr60 in response to insulin-like growth factor I. Insulin treatment of 3T3-L1 adipocytes stimulated WNK1 phosphorylation, as detected by immunoprecipitation with antibody against WNK1 followed by immunoblotting with the anti-phosphoAkt substrate antibody. WNK1 phosphorylation induced by insulin was unaffected by rapamycin, an inhibitor of p70 S6 kinase pathway but abolished by the PI3K inhibitor wortmannin. RNA interference-directed depletion of Akt1/PKB alpha and Akt2/PKB beta attenuated insulin-stimulated WNK1 phosphorylation, but depletion of protein kinase C lambda did not. Whereas small interfering RNA-induced loss of WNK1 protein did not significantly affect insulin-stimulated glucose transport in 3T3-L1 adipocytes, it significantly enhanced insulin-stimulated thymidine incorporation by about 2-fold. Furthermore, depletion of WNK1 promoted serum-stimulated cell proliferation of 3T3-L1 preadipocytes, as evidenced by a 36% increase in cell number after 48 h in culture. These data suggest that WNK1 is a physiologically relevant target of insulin signaling through PI3K and Akt/PKB and functions as a negative regulator of insulin-stimulated mitogenesis.


Subject(s)
Gene Expression Regulation, Enzymologic , Insulin/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , 3T3-L1 Cells , Adipocytes/metabolism , Androstadienes/pharmacology , Animals , Apoptosis , Binding Sites , Biological Transport , Cell Membrane/metabolism , Cell Proliferation , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Gene Expression Regulation , Glucose/metabolism , Humans , Immunoblotting , Immunoprecipitation , Intracellular Signaling Peptides and Proteins , Isoenzymes/metabolism , Mass Spectrometry , Mice , Minor Histocompatibility Antigens , Peptides/chemistry , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Kinase C/metabolism , Protein Structure, Tertiary , Protein Transport , Proto-Oncogene Proteins c-akt , RNA Interference , RNA, Small Interfering/metabolism , Receptor, Insulin/metabolism , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Signal Transduction , Sirolimus/pharmacology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Thymidine/metabolism , Time Factors , Transfection , Trypsin/pharmacology , WNK Lysine-Deficient Protein Kinase 1 , Wortmannin
9.
J Biol Chem ; 279(11): 10593-605, 2004 Mar 12.
Article in English | MEDLINE | ID: mdl-14676205

ABSTRACT

Here we identified two novel proteins denoted EH domain protein 2 (EHD2) and EHD2-binding protein 1 (EHBP1) that link clathrin-mediated endocytosis to the actin cytoskeleton. EHD2 contains an N-terminal P-loop and a C-terminal EH domain that interacts with NPF repeats in EHBP1. Disruption of EHD2 or EHBP1 function by small interfering RNA-mediated gene silencing inhibits endocytosis of transferrin into EEA1-positive endosomes as well as GLUT4 endocytosis into cultured adipocytes. EHD2 localizes with cortical actin filaments, whereas EHBP1 contains a putative actin-binding calponin homology domain. High expression of EHD2 or EHBP1 in intact cells mediates extensive actin reorganization. Thus EHD2 appears to connect endocytosis to the actin cytoskeleton through interactions of its N-terminal domain with membranes and its C-terminal EH domain with the novel EHBP1 protein.


Subject(s)
Actins/metabolism , Carrier Proteins/chemistry , Carrier Proteins/physiology , Cytoskeleton/metabolism , Endocytosis , 3T3-L1 Cells , Actins/chemistry , Adipocytes/metabolism , Amino Acid Sequence , Animals , Biological Transport , Blotting, Northern , Blotting, Western , COS Cells , Carrier Proteins/metabolism , Cell Membrane/metabolism , DNA, Complementary/metabolism , Endosomes/metabolism , Gene Silencing , Glucose/metabolism , Green Fluorescent Proteins , Humans , Immunohistochemistry , Luminescent Proteins/metabolism , Mice , Microscopy, Electron , Microscopy, Fluorescence , Models, Biological , Models, Genetic , Molecular Sequence Data , Protein Binding , Protein Structure, Tertiary , RNA, Small Interfering/metabolism , Rats , Rhodamines/chemistry , Time Factors , Tissue Distribution , Transfection , Transferrin/chemistry , Transferrin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...